Two drugs used to treat high blood pressure and depression will be withdrawn from the Taiwan market in early 2025 and late 2024, according to the Taiwan Food and Drug Administration (TFDA), which noted that locally produced generic drugs will fill the gap.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Society
Two fronts to bring cooler weather, rain to northern Taiwan: CWA
04/12/2026 07:56 PM -
Cross-Strait
Taiwan criticizes overtures from Beijing; opposition reaction mixed
04/12/2026 07:53 PM -
Culture
Booker-shortlisted novelist says Taiwan has more stories to tell
04/12/2026 07:43 PM -
Cross-Strait
China's Taiwan measures aim to deepen dependence: Scholar
04/12/2026 06:28 PM -
Business
Why are Taiwan's airlines betting big on North America?
04/12/2026 05:27 PM